CHIP, ICUS, CCUS and other four-letter words

Area of Science:

• Hematology
• Genetics
• Oncology

Background:

• Clonal hematopoiesis (CH) is the presence of somatic mutations in hematopoietic stem cells.
• Advances in DNA sequencing reveal CH is common across various clinical settings.
• The clinical implications of CH are highly context-dependent.

Purpose of the Study:

• To review the implications of clonal hematopoiesis in different clinical contexts.
• To highlight how understanding CH influences medical decision-making.
• To examine CH in normal aging, aplastic anemia, cytopenias, and chemotherapy patients.

Main Methods:

• Review of existing literature on clonal hematopoiesis.
• Analysis of the impact of clone size and driver mutations.
• Examination of CH in diverse patient populations.

Main Results:

• CH prevalence increases with age, particularly after 50.
• Small clones in healthy individuals are generally benign.
• Larger clones and more driver mutations in abnormal hematopoiesis indicate higher risk.

Conclusions:

• Understanding the clinical context of CH is crucial for risk stratification.
• CH assessment guides therapeutic strategies and patient counseling.
• CH has significant implications across various hematologic conditions.